Skip to content
PeptideStack
New:Share your peptide stack →

Longevity Stack

Epithalon and MOTS-C combined for telomere support, mitochondrial optimization, and cellular anti-aging.

Last updated:

Overview

The Longevity Stack represents a comprehensive approach to cellular anti-aging by targeting both nuclear and mitochondrial pathways. This peptide stack combines Epithalon, a renowned telomerase activator, with MOTS-c, a mitochondrial-derived peptide that regulates metabolic homeostasis. Researchers combine these specific compounds because they address distinct, complementary hallmarks of aging.

Epithalon works at the genomic level to extend cellular lifespan and regulate circadian rhythms. Conversely, MOTS-c optimizes energy production and preserves metabolic function. Together, this longevity stack offers a dual-action mechanism to investigate lifespan extension alongside healthspan preservation.

What Each Peptide Brings

  • Epitalon / Epithalon: Epithalon is a synthetic bioregulator designed to upregulate telomerase activity, thereby extending telomeres and increasing the Hayflick limit of somatic cells. Within this stack, it provides the genomic foundation for longevity by promoting cellular senescence delay. It also regulates circadian rhythms through targeted pineal gland modulation.
  • MOTS-c: MOTS-c is a naturally occurring mitochondrial peptide that functions as an exercise mimetic to enhance glucose metabolism and fatty acid oxidation. Its primary role in the stack is to combat age-related metabolic decline, preserve skeletal muscle, and optimize cellular energy pathways.

Synergy & Mechanism

Dual-pathway targeting forms the foundation of this longevity stack, addressing aging from both the nucleus and the mitochondria. While Epithalon focuses on extending chromosomal telomeres to delay cellular senescence, MOTS-c ensures these prolonged cells maintain the metabolic capacity required to function optimally. This complementary mechanism means researchers can investigate physiological lifespan extension alongside metabolic healthspan preservation.

Metabolic and circadian synchronization further enhances the synergistic effects of these combined peptides. Epithalon restores youthful circadian rhythms by modulating melatonin secretion, naturally improving sleep architecture and cellular repair phases. Concurrently, MOTS-c improves insulin sensitivity and cellular energy availability, creating a highly restorative environment that maximizes natural regenerative processes during rest.

Combined Benefits

  • Telomere Extension: Epitalon activates the telomerase enzyme, which elongates telomeres and potentially increases the Hayflick limit of somatic cells Khavinson VKh, 2002.
  • Metabolic Homeostasis: MOTS-c significantly improves insulin sensitivity and reduces obesity by targeting skeletal muscle metabolism Lee et al., 2015.
  • Muscle Preservation: The stack helps combat sarcopenia by reducing myostatin expression and attenuating muscle atrophy signaling pathways Kumagai et al., 2021.
  • Lifespan Prolongation: Animal models demonstrate that Epitalon administration significantly increases lifespan while suppressing the development of spontaneous tumors Anisimov VN et al., 2002.
  • Glycemic Control: Clinical and preclinical data show the combination relieves hyperglycemia and improves insulin resistance Yin et al., 2022.
  • Circadian Rhythm Regulation: By influencing pineal secretion and melatonin production, the stack helps restore natural sleep-wake cycles essential for optimal cellular repair.

Considerations

Potential side effects and interactions:

  • Injection site reactions such as localized redness or mild swelling
  • Mild alterations in blood glucose levels requiring monitoring
  • Potential disruption of sleep patterns if Epithalon is administered incorrectly
  • Temporary fatigue or headaches during initial acclimatization phases
  • Theoretical interactions with blood sugar lowering medications due to MOTS-c

Timing and scheduling: Research dosing typically schedules Epithalon as a cyclical protocol of 10-20 days twice a year injected in the evening, while MOTS-c is generally administered 1-3 times weekly prior to physical activity.

Peptide stacks are for research purposes only. Individual responses vary. Consult a qualified healthcare provider before combining any peptides.

Frequently Asked Questions

Peptides in This Stack